Company Overview
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Company Information
- CEO
- Bryan C. Hanson
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 22000
Contact Information
- Website
- https://www.solventum.com
- Address
- 3M Center
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 12.27B market capitalization
- Trading Volume: 1.64M shares traded today
- Price Range: 52-week range of $58.76 - $85.92
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Solventum Corporation
Solventum Corporation (SOLV) operates in the Medical - Care Facilities industry within the Healthcare sector. With a current market capitalization of 12.27B, the company represents a significant player in its market. The stock is currently trading at $70.76 with a negativedaily change of 0.92%.
The company's 22000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 32.46, beta of 0.66, and 52-week price range from $58.76 to $85.92when evaluating investment opportunities.
Why Invest in Solventum Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Bryan C. Hanson
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.